arrow_back Back to App

Mandatory Newborn Screening for Congenital Cytomegalovirus (CMV) Infection

This Act allows for the screening of newborns up to 21 days old for congenital Cytomegalovirus (CMV) in hospitals. The goal is early detection of this condition, which can cause serious health issues in children. Furthermore, the law allocates funds for research, diagnostic development, and public education regarding CMV, enhancing the health security of the youngest citizens.
Key points
Introduction of congenital Cytomegalovirus (CMV) screening for infants up to 21 days old in healthcare facilities.
Provision of grants to states to develop screening standards, data collection, and education for healthcare providers and the public about CMV.
Increased funding for research by the National Institutes of Health (NIH) into new screening techniques, diagnostics, prevention, and treatment of congenital CMV.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_5435
Sponsor: Rep. Lawler, Michael [R-NY-17]
Process start date: 2025-09-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Stop CMV Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5435.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-17.

What are the main provisions?

Key points include:

  • Introduction of congenital Cytomegalovirus (CMV) screening for infants up to 21 days old in healthcare facilities.
  • Provision of grants to states to develop screening standards, data collection, and education for healthcare providers and the public about CMV.
  • Increased funding for research by the National Institutes of Health (NIH) into new screening techniques, diagnostics, prevention, and treatment of congenital CMV.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Lawler, Michael [R-NY-17].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-31.

CATEGORIES

Health Family